Note: Originally published on Nov. 12, 2025, this resource is updated as needed, most recently on August 12, 2026, to reflect additional developments.
Since the inauguration of President Donald Trump for his second term, the Department of Health and Human Services (HHS) has become the epicenter of a fundamental reorientation of American public health. Under the leadership of Secretary Robert F. Kennedy, Jr., the administration has moved to dismantle long-standing institutional norms, shift research priorities toward a "Make America Healthy Again" (MAHA) framework, and aggressively restructure the federal workforce. These changes have prompted a wave of litigation, internal turbulence, and intense scrutiny from the scientific community.
The Philosophical Shift: The "Make America Healthy Again" Era
The central pillar of the current administration’s health agenda is the "Make America Healthy Again" (MAHA) initiative. Established via Executive Order on February 13, 2025, this policy seeks to pivot the national health focus from infectious disease management toward the mitigation of chronic conditions, which Secretary Kennedy has argued are driven by environmental toxins, food additives, and "over-medicalization."
This shift has manifested in the reorganization of HHS, the termination of specific research grants, and a fundamental questioning of the established childhood immunization schedule. By decoupling federal health strategy from historical consensus and moving toward a model that emphasizes individual decision-making and parental choice, the administration has fundamentally altered the relationship between the federal government and the American public health infrastructure.
Chronology of Key Policy Actions
The scope of the administration’s activity is vast, affecting everything from data transparency to the fundamental structure of the FDA and CDC.
Early 2025: Administrative Realignment
- January 20, 2025: President Trump issues Executive Orders revoking Biden-era guidance on diversity, equity, and inclusion (DEI) and "gender ideology." HHS responds by removing thousands of webpages and databases related to health disparities, LGBTQ+ health, and reproductive health. While the administration agreed to restore these sites in September 2025, the initial removal sparked national alarm over the accessibility of federal data.
- February 13, 2025: Robert F. Kennedy, Jr. is confirmed as HHS Secretary.
- February 14, 2025: The administration initiates a "reduction in force" (RIF) across HHS, part of a broader government-wide efficiency push. By August 2025, an estimated 20,000 HHS jobs had been eliminated.
- February 28, 2025: Secretary Kennedy rescinds the "Richardson Waiver," ending the requirement for public notice and comment on HHS grants and contracts, significantly streamlining the department’s ability to change policy without public input.
Spring and Summer 2025: Vaccine Policy and Agency Turnover
- March 25, 2025: HHS attempts to claw back $11.4 billion in supplemental COVID-19 funding from state and local health departments. A series of lawsuits ensues; while funds are restored to many blue-leaning states, Republican-led states remain largely affected by the cuts.
- May 27, 2025: Secretary Kennedy announces the removal of COVID-19 vaccines for healthy children and pregnant women from the CDC recommended schedule, bypassing the traditional Advisory Committee on Immunization Practices (ACIP) review process.
- June 9, 2025: In an unprecedented move, Secretary Kennedy dismisses all 17 sitting members of ACIP, replacing them with appointees who have frequently expressed skepticism regarding standard vaccination policies.
- July 31, 2025: The administration removes Susan Monarez as CDC Director just 28 days after her confirmation, citing disagreements over vaccine policy and personnel firings.
Late 2025 – 2026: Institutional Challenges and Judicial Intervention
- October 10, 2025: During a government shutdown, thousands of HHS employees are notified of termination, with the bulk of losses concentrated at the CDC.
- January 5, 2026: HHS issues a new childhood vaccination schedule, recommending routine vaccines for only 11 diseases, down from 17. The policy is later stayed by a federal judge in March 2026 due to procedural violations.
- May 29, 2026: A new Executive Order directs HHS to align the U.S. vaccine schedule with "peer, developed countries," a strategy repeated in an August 2026 EO.
Supporting Data and Research Impact
The administration’s policy changes have had measurable impacts on the federal research landscape. The cancellation of $500 million in mRNA vaccine research through the Biomedical Advanced Research and Development Authority (BARDA) in August 2025 marked a significant retreat from a technology that had been crucial to pandemic response.
Furthermore, the "National Priority Voucher" program, established in June 2025, attempts to fast-track drug approvals for products deemed to serve the "U.S. national interest." While intended to spur innovation, critics argue this places immense strain on an already depleted FDA staff, leading to longer review times for standard, non-vouchered medications.
The administration’s focus on the link between acetaminophen and autism—a claim based on controversial reports—has redirected resources, even as the scientific consensus maintains that vaccines do not cause autism. The September 2025 announcement to encourage clinicians to limit acetaminophen use during pregnancy reflects a broader trend of the administration elevating "alternative" health narratives to official status.
Official Responses and Stakeholder Criticism
The reaction from the professional medical community has been largely negative. Organizations including the American Medical Association (AMA), the American Academy of Pediatrics (AAP), and the American College of Obstetricians and Gynecologists (ACOG) have been vocal in their opposition.
- Public Health Groups: Organizations have consistently challenged the administration in court. The ongoing litigation by 16 states and the District of Columbia regarding teen pregnancy prevention grants and the AAP’s lawsuit against changes to the childhood immunization schedule represent a sustained attempt to force the administration to adhere to the Administrative Procedure Act.
- The Administration’s Defense: Secretary Kennedy and White House officials frame these actions as necessary "house cleaning." They argue that the previous bureaucracy was captured by industry interests and that their actions restore "scientific rigor" and "public trust." Kennedy has consistently stated that his goal is to return public health decision-making to parents and local providers rather than federal mandates.
Implications for the Future of Public Health
The long-term implications of these actions are profound and potentially irreversible.
1. Fragmentation of Care
By moving toward "shared clinical decision-making" for vaccines that were previously universally recommended, the administration has decentralized the U.S. immunization strategy. While this may increase parental choice, public health experts warn it will lead to geographic disparities in vaccination rates, as access and advice will vary significantly by state and local provider.
2. Erosion of Institutional Expertise
The mass departure of career scientists, coupled with the dismantling of key research programs (such as the monkey research programs at the CDC and the "Safe to Sleep" infant mortality campaign), risks creating a "brain drain" at HHS. The loss of institutional memory in agencies like the CDC and NIH could hamper the nation’s ability to respond to future public health emergencies, including emerging threats like H5N1 (bird flu).
3. Judicial Oversight
The judiciary has emerged as the primary check on the administration’s authority. From the permanent injunctions against NIH indirect cost rate cuts to the stays on vaccine schedule changes, the courts have repeatedly found that the administration failed to follow federal notice-and-comment requirements. This ongoing friction suggests that the administration’s health agenda will remain mired in legal battles for the foreseeable future.
4. Public Trust
The administration’s rhetoric regarding vaccines—specifically the November 2025 update to the CDC website suggesting a link between vaccines and autism cannot be ruled out—represents a departure from decades of established public health messaging. The result is a highly polarized environment where "official" health guidance is increasingly viewed through a political lens, potentially undermining public confidence in all health-related communications.
Conclusion
The Trump administration’s tenure at HHS has been characterized by a radical departure from the status quo. By prioritizing the MAHA agenda, the administration has successfully implemented significant structural changes, yet these changes have come at the cost of intense organizational instability and widespread opposition from the medical establishment. As the administration enters the latter half of its term, the tension between its populist health platform and the requirements of federal law continues to define the landscape of American public health.
About the Author
